This novel anti-infective, invented by Orchid Pharma, aims to address the rising threat of antimicrobial resistance (AMR) and has been approved for the treatment of complicated urinary tract infections (cUTI), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP)
Read More
Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by 2050
Read More
The disease, often asymptomatic until it progresses to severe stages like cirrhosis or liver cancer, is exacerbated by prevalent genetic predispositions to insulin resistance among Indians
Read More
Amrita Vishwa Vidyapeetham launches BTech, MTech Programs in AI and Data Science
Read More
The launch event featured prominent figures from the film industry, including Hal Sadoff, producer of "Hotel Rwanda," and William Pfiefer, who significantly brought Sony to India
Read More
